Hope for powerful new C diff. treatment
Monday, September 19, 2011 - 15:00
in Health & Medicine
MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly MRSA and Clostridium difficile (C. diff.) bugs.